Vorsetuzumab mafodotin is a humanized anti-CD70 monoclonal antibody attached to a potent, synthetic drug payload, monomethyl auristatin F (MMAF) utilizing Seattle Genetics proprietary antibody-drug conjugate (ADC) technology. CD70 is expressed on a vari